SMARCA2 and carcinoid tumor: No genetic alteration was exclusive to a specific LNET subtype, but the differences between carcinoids and carcinomas reside in the prevalence rates of the most frequently mutated genes, with the exception of SMARCA2, which was altered in LCNECs only (p = 0.011).